Labat Africa (JSE:LAB) 9-Day RSI: 89.34 (As of Jun. 26, 2026)


What is Labat Africa 9-Day RSI?

Labat Africa JSE:LAB 9-Day RSI is 89.34 as of Jun. 26, 2026. The stock has 5 warning signs investors should review. Among 1,049 Drug Manufacturers companies, Labat Africa ranks worse than 98.57% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-06-26), Labat Africa's 9-Day RSI is 89.34.

The industry rank for Labat Africa's 9-Day RSI or its related term are showing as below:

JSE:LAB's 9-Day RSI is ranked worse than
98.57% of 1049 companies
in the Drug Manufacturers industry
Industry Median: 44.18 vs JSE:LAB: 89.34

Labat Africa  (JSE:LAB) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Labat Africa 9-Day RSI Related Terms


JSE:LAB vs ZTS, UTHR, VTRS: 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labat Africa 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labat Africa's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Labat Africa's 9-Day RSI falls into.



Labat Africa  (JSE:LAB) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 89.34 mean?
Labat Africa (JSE:LAB) has a 9-Day RSI of 89.34 as of Jun. 26, 2026. According to the industry distribution chart, Labat Africa ranks #1034 out of 1049 companies in the Drug Manufacturers industry, placing it in the top 98.6%.
Is Labat Africa's 9-Day RSI too high?
Labat Africa's current 9-Day RSI is 89.34. The Drug Manufacturers industry median 9-Day RSI is 44.18. Labat Africa's value of 89.34 is 102.2% above this industry median. Based on the distribution chart, Labat Africa ranks #1034 out of 1049 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Labat Africa's 9-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #1034 out of 1049 companies for 9-Day RSI. This places Labat Africa in the lower half of its industry. The industry median 9-Day RSI is 44.18. Labat Africa's value of 89.34 is 102.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 44.18, based on 1,049 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current 9-Day RSI of 89.34 is 102.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 44.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current 9-Day RSI is 89.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current 9-Day RSI is 89.34 and 102.2% above the Drug Manufacturers industry median of 44.18. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current 9-Day RSI is 89.34 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.